Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - LOVE RICHARD L
Last Updated 
20-Nov-09
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

LOVE RICHARD L: Declared Holdings
Company/RelationshipReportedShares  Ownership
Cell Therapeutics, Inc.
Director
NasdaqCM:CTIC
(historical quotes, profile, SEC, other insiders)
13-Nov-09857,422  Direct
IMARX THERAPEUTICS
Director
OTC BB:IMRX.OB
(historical quotes, profile, other insiders)
21-Aug-09348,810  Direct
PAREXEL International Corporati
Director
NasdaqGS:PRXL
(historical quotes, profile, SEC, other insiders)
10-Sep-0980,207  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
13-Nov-09 290,017CTIC Acquisition (Non Open Market) at $0 per share.
20-Oct-09 20,000CTIC Acquisition (Non Open Market) at $0 per share.
10-Sep-09 12,900PRXL Acquisition (Non Open Market) at $0 per share.
21-Aug-09 300,000IMRX.OB Acquisition (Non Open Market) at $0 per share.
12-Aug-09 70,000CTIC Sale at $1.64 per share.
(Proceeds of $114,800)
31-Jul-09 214,966CTIC Acquisition (Non Open Market) at $0 per share.
1-Apr-09 321,839CTIC Acquisition (Non Open Market) at $0 per share.
7-Jan-09 4,451,513CTIC Acquisition (Non Open Market)
30-Oct-08 2,000PRXL Purchase at $10.34 per share.
(Cost of $20,680)
22-Oct-08 25,000CTIC Acquisition (Non Open Market) at $0 per share.
11-Sep-08 6,307PRXL Acquisition (Non Open Market) at $0 per share.
30-May-08 23,810IMRX.OB Acquisition (Non Open Market) at $0 per share.


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?